E
Eko International Corp. Stock Analysis EKNL
EKO International Corp. operates as a holding company. The company is headquartered in Burlington, Ontario. The company went IPO on 2001-11-28. The firm focuses on examining a range of proposed target businesses and if interested, intends to negotiate terms and conditions of purchase favorable to it. The firm holds interests in NeuroVasc Clinical Inc. The business of NeuroVasc Clinical Inc. is to promote and distribute Frequency Rhythmic Electrical Modulation System (FREMS) equipment supplied by Lorenz Neurovasc Inc.; set up and/or manage clinics to treat patients using FREMS equipment, and set up training and certification centers for technicians in the use of FREMS equipment. FREMS equipment is used in the treatment of peripheral neuropathy, which is damage to nerves in extremities, such as lower legs and feet, causing an interruption in communication between the brain and parts of the body with damaged nerves.
Read More Eko International Corp (EKNL) Chart
Key Statistics of Eko International Corp (EKNL)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
30.00KP/E Ratio (TTM)
-52 Week Range
Market Cap
3168.30Avg. Volume
30.00KDividend Yield
-Financial Metrics & Statements of Eko International Corp (EKNL)
FAQ's for Eko International Corp (EKNL)
- According to Musaffa’s Shariah screening methodology, Eko International Corp (EKNL) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.